Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 0.36
USPH's Cash-to-Debt is ranked higher than
53% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 0.32 vs. USPH: 0.36 )
Ranked among companies with meaningful Cash-to-Debt only.
USPH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.24  Med: 0.77 Max: 298.04
Current: 0.36
0.24
298.04
Equity-to-Asset 0.58
USPH's Equity-to-Asset is ranked higher than
66% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 0.46 vs. USPH: 0.58 )
Ranked among companies with meaningful Equity-to-Asset only.
USPH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.69 Max: 0.85
Current: 0.58
0.31
0.85
Interest Coverage 41.96
USPH's Interest Coverage is ranked higher than
77% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 7.01 vs. USPH: 41.96 )
Ranked among companies with meaningful Interest Coverage only.
USPH' s Interest Coverage Range Over the Past 10 Years
Min: 41.96  Med: 67.76 Max: N/A
Current: 41.96
Piotroski F-Score: 6
Altman Z-Score: 6.21
Beneish M-Score: -2.81
WACC vs ROIC
9.35%
14.80%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 14.53
USPH's Operating Margin % is ranked higher than
77% of the 218 Companies
in the Global Medical Care industry.

( Industry Median: 6.53 vs. USPH: 14.53 )
Ranked among companies with meaningful Operating Margin % only.
USPH' s Operating Margin % Range Over the Past 10 Years
Min: 12.72  Med: 14.16 Max: 15.71
Current: 14.53
12.72
15.71
Net Margin % 6.84
USPH's Net Margin % is ranked higher than
64% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 4.07 vs. USPH: 6.84 )
Ranked among companies with meaningful Net Margin % only.
USPH' s Net Margin % Range Over the Past 10 Years
Min: 4.66  Med: 6.29 Max: 9.06
Current: 6.84
4.66
9.06
ROE % 14.32
USPH's ROE % is ranked higher than
71% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 9.23 vs. USPH: 14.32 )
Ranked among companies with meaningful ROE % only.
USPH' s ROE % Range Over the Past 10 Years
Min: 10.36  Med: 14.33 Max: 19.88
Current: 14.32
10.36
19.88
ROA % 8.08
USPH's ROA % is ranked higher than
76% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 3.61 vs. USPH: 8.08 )
Ranked among companies with meaningful ROA % only.
USPH' s ROA % Range Over the Past 10 Years
Min: 6.43  Med: 9.79 Max: 13.79
Current: 8.08
6.43
13.79
ROC (Joel Greenblatt) % 123.45
USPH's ROC (Joel Greenblatt) % is ranked higher than
90% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 15.77 vs. USPH: 123.45 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
USPH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 45.91  Med: 117.53 Max: 149.88
Current: 123.45
45.91
149.88
3-Year Revenue Growth Rate 8.40
USPH's 3-Year Revenue Growth Rate is ranked higher than
51% of the 182 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. USPH: 8.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
USPH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 7.1  Med: 12.7 Max: 17.4
Current: 8.4
7.1
17.4
3-Year EBITDA Growth Rate 6.70
USPH's 3-Year EBITDA Growth Rate is ranked lower than
54% of the 162 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. USPH: 6.70 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
USPH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -0.3  Med: 13.6 Max: 25.8
Current: 6.7
-0.3
25.8
3-Year EPS without NRI Growth Rate 5.00
USPH's 3-Year EPS without NRI Growth Rate is ranked lower than
57% of the 136 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. USPH: 5.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
USPH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -1.2  Med: 12.6 Max: 57.8
Current: 5
-1.2
57.8
GuruFocus has detected 3 Warning Signs with US Physical Therapy Inc $USPH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» USPH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

USPH Guru Trades in Q1 2016

Paul Tudor Jones 11,900 sh (New)
Jim Simons 638,100 sh (-7.68%)
Chuck Royce 321,025 sh (-47.92%)
» More
Q2 2016

USPH Guru Trades in Q2 2016

Chuck Royce 321,025 sh (unchged)
Paul Tudor Jones Sold Out
Jim Simons 575,174 sh (-9.86%)
» More
Q3 2016

USPH Guru Trades in Q3 2016

Joel Greenblatt 5,232 sh (New)
Jim Simons 573,654 sh (-0.26%)
Chuck Royce 318,425 sh (-0.81%)
» More
Q4 2016

USPH Guru Trades in Q4 2016

Jim Simons 591,700 sh (+3.15%)
Joel Greenblatt Sold Out
Chuck Royce 317,825 sh (-0.19%)
» More
» Details

Insider Trades

Latest Guru Trades with USPH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621498    SIC: 8093
Compare:NAS:BIOS » details
Traded in other countries:UPH.Germany,
US Physical Therapy Inc operates outpatient physical and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, preventative care, and rehabilitation of injured workers among others.

US Physical Therapy operates outpatient physical therapy and occupational therapy clinics throughout the United States. Its clinics provide treatment for orthopedic disorders, sports-related injuries, and work-related injuries. The company also administers care designed to prevent injuries from occurring. At the start of 2002, the company operated 170 clinics in more than 30 states.

Ratios

vs
industry
vs
history
PE Ratio 32.98
USPH's PE Ratio is ranked lower than
60% of the 279 Companies
in the Global Medical Care industry.

( Industry Median: 28.41 vs. USPH: 32.98 )
Ranked among companies with meaningful PE Ratio only.
USPH' s PE Ratio Range Over the Past 10 Years
Min: 8.91  Med: 20.35 Max: 38.66
Current: 32.98
8.91
38.66
Forward PE Ratio 30.30
USPH's Forward PE Ratio is ranked lower than
80% of the 98 Companies
in the Global Medical Care industry.

( Industry Median: 19.01 vs. USPH: 30.30 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 32.98
USPH's PE Ratio without NRI is ranked lower than
62% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 27.34 vs. USPH: 32.98 )
Ranked among companies with meaningful PE Ratio without NRI only.
USPH' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.91  Med: 19.16 Max: 38.66
Current: 32.98
8.91
38.66
Price-to-Owner-Earnings 25.46
USPH's Price-to-Owner-Earnings is ranked higher than
58% of the 97 Companies
in the Global Medical Care industry.

( Industry Median: 28.18 vs. USPH: 25.46 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
USPH' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.5  Med: 20.64 Max: 60.43
Current: 25.46
5.5
60.43
PB Ratio 4.50
USPH's PB Ratio is ranked lower than
73% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 2.42 vs. USPH: 4.50 )
Ranked among companies with meaningful PB Ratio only.
USPH' s PB Ratio Range Over the Past 10 Years
Min: 1.12  Med: 2.68 Max: 5.25
Current: 4.5
1.12
5.25
PS Ratio 2.24
USPH's PS Ratio is ranked lower than
63% of the 270 Companies
in the Global Medical Care industry.

( Industry Median: 1.55 vs. USPH: 2.24 )
Ranked among companies with meaningful PS Ratio only.
USPH' s PS Ratio Range Over the Past 10 Years
Min: 0.48  Med: 1.23 Max: 2.65
Current: 2.24
0.48
2.65
Price-to-Free-Cash-Flow 16.91
USPH's Price-to-Free-Cash-Flow is ranked higher than
71% of the 134 Companies
in the Global Medical Care industry.

( Industry Median: 26.27 vs. USPH: 16.91 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
USPH' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 3.33  Med: 10.38 Max: 19.8
Current: 16.91
3.33
19.8
Price-to-Operating-Cash-Flow 14.68
USPH's Price-to-Operating-Cash-Flow is ranked lower than
51% of the 191 Companies
in the Global Medical Care industry.

( Industry Median: 14.39 vs. USPH: 14.68 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
USPH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.83  Med: 8.74 Max: 17.19
Current: 14.68
2.83
17.19
EV-to-EBIT 16.92
USPH's EV-to-EBIT is ranked higher than
58% of the 290 Companies
in the Global Medical Care industry.

( Industry Median: 19.26 vs. USPH: 16.92 )
Ranked among companies with meaningful EV-to-EBIT only.
USPH' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.9  Med: 8.8 Max: 19.6
Current: 16.92
3.9
19.6
EV-to-EBITDA 14.53
USPH's EV-to-EBITDA is ranked lower than
51% of the 303 Companies
in the Global Medical Care industry.

( Industry Median: 14.06 vs. USPH: 14.53 )
Ranked among companies with meaningful EV-to-EBITDA only.
USPH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.1  Med: 7.5 Max: 16.8
Current: 14.53
3.1
16.8
PEG Ratio 5.38
USPH's PEG Ratio is ranked lower than
71% of the 90 Companies
in the Global Medical Care industry.

( Industry Median: 3.02 vs. USPH: 5.38 )
Ranked among companies with meaningful PEG Ratio only.
USPH' s PEG Ratio Range Over the Past 10 Years
Min: 0.8  Med: 1.62 Max: 5.96
Current: 5.38
0.8
5.96
Shiller PE Ratio 45.47
USPH's Shiller PE Ratio is ranked lower than
74% of the 46 Companies
in the Global Medical Care industry.

( Industry Median: 28.27 vs. USPH: 45.47 )
Ranked among companies with meaningful Shiller PE Ratio only.
USPH' s Shiller PE Ratio Range Over the Past 10 Years
Min: 11.61  Med: 26.09 Max: 53.19
Current: 45.47
11.61
53.19
Current Ratio 2.53
USPH's Current Ratio is ranked higher than
85% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 1.28 vs. USPH: 2.53 )
Ranked among companies with meaningful Current Ratio only.
USPH' s Current Ratio Range Over the Past 10 Years
Min: 1.63  Med: 4.03 Max: 16.64
Current: 2.53
1.63
16.64
Quick Ratio 2.53
USPH's Quick Ratio is ranked higher than
87% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. USPH: 2.53 )
Ranked among companies with meaningful Quick Ratio only.
USPH' s Quick Ratio Range Over the Past 10 Years
Min: 1.63  Med: 4.03 Max: 16.64
Current: 2.53
1.63
16.64
Days Sales Outstanding 42.25
USPH's Days Sales Outstanding is ranked higher than
52% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 44.02 vs. USPH: 42.25 )
Ranked among companies with meaningful Days Sales Outstanding only.
USPH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 40.46  Med: 45.36 Max: 64.31
Current: 42.25
40.46
64.31
Days Payable 2.97
USPH's Days Payable is ranked lower than
99% of the 143 Companies
in the Global Medical Care industry.

( Industry Median: 40.41 vs. USPH: 2.97 )
Ranked among companies with meaningful Days Payable only.
USPH' s Days Payable Range Over the Past 10 Years
Min: 2.36  Med: 3.31 Max: 5.88
Current: 2.97
2.36
5.88

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.05
USPH's Dividend Yield % is ranked lower than
70% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 1.65 vs. USPH: 1.05 )
Ranked among companies with meaningful Dividend Yield % only.
USPH' s Dividend Yield % Range Over the Past 10 Years
Min: 0.31  Med: 1.23 Max: 1.74
Current: 1.05
0.31
1.74
Dividend Payout Ratio 0.34
USPH's Dividend Payout Ratio is ranked higher than
68% of the 145 Companies
in the Global Medical Care industry.

( Industry Median: 0.39 vs. USPH: 0.34 )
Ranked among companies with meaningful Dividend Payout Ratio only.
USPH' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.2  Med: 0.28 Max: 0.34
Current: 0.34
0.2
0.34
3-Year Dividend Growth Rate 18.60
USPH's 3-Year Dividend Growth Rate is ranked higher than
65% of the 79 Companies
in the Global Medical Care industry.

( Industry Median: 10.10 vs. USPH: 18.60 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
USPH' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 18.6
Current: 18.6
0
18.6
Forward Dividend Yield % 1.07
USPH's Forward Dividend Yield % is ranked lower than
68% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 1.84 vs. USPH: 1.07 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.05
USPH's 5-Year Yield-on-Cost % is ranked lower than
79% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 2.17 vs. USPH: 1.05 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
USPH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.31  Med: 1.23 Max: 1.74
Current: 1.05
0.31
1.74
3-Year Average Share Buyback Ratio -1.40
USPH's 3-Year Average Share Buyback Ratio is ranked higher than
60% of the 129 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. USPH: -1.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
USPH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -9.8  Med: -0.5 Max: 7.7
Current: -1.4
-9.8
7.7

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.36
USPH's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
72% of the 137 Companies
in the Global Medical Care industry.

( Industry Median: 2.07 vs. USPH: 1.36 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
USPH' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.38  Med: 0.93 Max: 3.08
Current: 1.36
0.38
3.08
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.12
USPH's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
59% of the 51 Companies
in the Global Medical Care industry.

( Industry Median: 1.83 vs. USPH: 2.12 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.84
USPH's Price-to-Median-PS-Value is ranked lower than
85% of the 246 Companies
in the Global Medical Care industry.

( Industry Median: 1.09 vs. USPH: 1.84 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
USPH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.46  Med: 1.05 Max: 2.43
Current: 1.84
0.46
2.43
Price-to-Peter-Lynch-Fair-Value 4.79
USPH's Price-to-Peter-Lynch-Fair-Value is ranked lower than
88% of the 80 Companies
in the Global Medical Care industry.

( Industry Median: 2.23 vs. USPH: 4.79 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
USPH' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.47  Med: 1.54 Max: 5.85
Current: 4.79
0.47
5.85
Earnings Yield (Greenblatt) % 5.90
USPH's Earnings Yield (Greenblatt) % is ranked higher than
65% of the 332 Companies
in the Global Medical Care industry.

( Industry Median: 4.31 vs. USPH: 5.90 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
USPH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.1  Med: 11.4 Max: 25.9
Current: 5.9
5.1
25.9
Forward Rate of Return (Yacktman) % 11.92
USPH's Forward Rate of Return (Yacktman) % is ranked higher than
56% of the 119 Companies
in the Global Medical Care industry.

( Industry Median: 10.14 vs. USPH: 11.92 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
USPH' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 10.8  Med: 19.6 Max: 29.2
Current: 11.92
10.8
29.2

More Statistics

Revenue (TTM) (Mil) $352.4
EPS (TTM) $ 1.94
Beta0.98
Short Percentage of Float6.43%
52-Week Range $46.29 - 78.00
Shares Outstanding (Mil)12.52

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 357 387 420
EPS ($) 1.85 2.10 2.32
EPS without NRI ($) 1.85 2.10 2.32
EPS Growth Rate
(Future 3Y To 5Y Estimate)
10.00%
Dividends per Share ($)
» More Articles for USPH

Headlines

Articles On GuruFocus.com
USPH: A Small Cap with Big Cap Predictability Oct 08 2014 
Four 'Boring' Stocks to Consider Sep 30 2014 
12 Healthcare Dividend Stocks with Gaining Earnings Momentum Apr 02 2012 
U.S. Physical Therapy Inc. (USPH) CEO Christopher J Reading sells 25,000 Shares Mar 11 2011 
U.S. Physical Therapy Inc. (USPH) COO Glenn Mcdowell sells 10,614 Shares Mar 11 2011 
U.S. Physical Therapy Inc. Reports Operating Results (10-K) Mar 10 2011 
U.S. Physical Therapy Inc. (USPH) CFO Lawrance W Mcafee sells 5,000 Shares Mar 09 2011 
U.S. Physical Therapy Inc. (USPH) CFO Lawrance W Mcafee sells 15,000 Shares Mar 04 2011 
U.S. Physical Therapy Inc. (USPH) CFO Lawrance W Mcafee sells 5,000 Shares Dec 27 2010 
U.S. Physical Therapy Inc. Reports Operating Results (10-Q) Nov 04 2010 

More From Other Websites
Lifshitz & Miller LLP Announces Investigation of Adeptus Health Inc., AmTrust Financial Services,... Mar 24 2017
Pawar Law Group Announces Investigation of Securities Claims Against U.S. Physical Therapy, Inc. -... Mar 24 2017
INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of U.S. Physical... Mar 24 2017
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 23 2017
U.S. Physical Therapy Acquires Industrial Services Provider Mar 23 2017
SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of U.S. Physical Therapy, Inc. and... Mar 22 2017
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of U.S. Physical... Mar 22 2017
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of U.S. Physical Therapy,... Mar 21 2017
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of U.S. Physical... Mar 21 2017
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K, Other Events Mar 20 2017
U.S. Physical Therapy, Inc. Investigated For Securities Fraud By Block & Leviton After Announcing... Mar 17 2017
U.S. Physical Therapy, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe Investigates... Mar 17 2017
SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of U.S. Physical Therapy, Inc. and... Mar 17 2017
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against U.S. Physical... Mar 17 2017
U.S. Physical Therapy downgraded by Barrington Research Mar 17 2017
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of U.S. Physical Therapy,... Mar 16 2017
USPH NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of... Mar 16 2017
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of U.S. Physical Therapy, Inc.,... Mar 16 2017
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of U.S. Physical... Mar 16 2017
Glancy Prongay & Murray LLP Commences Investigation on Behalf of U.S. Physical Therapy, Inc.... Mar 16 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)